Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2007-05-22

FDA Approved: MESALAMINE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)

View source ↗

Summary

FDA approved a supplemental application for MESALAMINE from Padagis Israel Pharmaceuticals Ltd under an ANDA. The approval signifies a supplemental change to th…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)